Singapore markets closed

NanoEntek, Inc. (039860.KQ)

KOSDAQ - KOSDAQ Delayed Price. Currency in KRW
Add to watchlist
5,440.00+200.00 (+3.82%)
At close: 03:30PM KST

NanoEntek, Inc.

5, Digital-ro 26-gil
12th Floor Guro-gu
Seoul 08389
South Korea
82 2 6220 7728

Full-time employees137

Key executives

NameTitlePayExercisedYear born
Mr. Jin-Hyung ParkChief Exec. Officer and DirectorN/AN/A1967
Mr. Han-Sang ChoSr. Managing DirectorN/AN/A1967
Mr. Chan-Il JeongSr. Managing DirectorN/AN/A1969
Mr. Hee-Don AnManaging DirectorN/AN/A1968
Ms. Sun-Mee HanManaging DirectorN/AN/A1973
Mr. Jung-Goo SeoVice-Pres and DirectorN/AN/A1962
Amounts are as of 31 December 2012, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.


NanoEnTek Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a quantitative fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, an analytical device for counting the residual white blood cells; ADAMII, a fluorescence stem cell counter; EVE, a benchtop counter to measure cell count and viability; Arthur/fluorescence cell counters; automated somatic cell counters; live-cell imaging system; and disposable hemocytometers. The company was founded in 2000 and is headquartered in Seoul, South Korea.

Corporate governance

NanoEntek, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.